Literature DB >> 20104274

Jk(a-b-) phenotype screening by the urea lysis test in Thai blood donors.

Suparat Deelert1, Pattrawan Thippayaboon, Wimolpak Sriwai, Pramote Sriwanitchrak, Jintana Tubrod, Pawinee Kupatawintu, Oytip Nathalang.   

Abstract

BACKGROUND: The Jk(a-b-) phenotype is rare in most populations and often detected after transfusion or pregnancy. After immunisation, anti-Jk3 forms and it can be difficult to find compatible Jk(a-b-) donors. Using anti-Jk(a) and anti-Jk(b) in a conventional tube method is unsuitable for identifying Jk(a-b-) in mass screening of blood donors. Jk(a-b-) phenotypes are associated with the absence of urea transporters on erythrocytes, making red blood cells (RBC) resistant to lysis by 2M urea, while Jk(a+b-), Jk(a-b+) and Jk(a+b+) phenotypes are susceptible to lysis.
MATERIALS AND METHODS: We screened for Jk(a-b-) phenotypes in blood donors by the urea lysis test using a 96-well microplate. The Jk(a-b-) phenotypes were confirmed by the indirect antiglobulin test (IAT).
RESULTS: Altogether, 20,163 blood samples from Thai blood donors were tested and only RBC from five samples were resistant to lysis by 2M urea, while 20,158 samples were completely lysed within 5 min. In an IAT, both anti-Jk(a) and anti-Jk(b) failed to agglutinate RBC from all five samples. Using a micro-titre plate, the direct urea lysis test, costs * 0.01, about 480 times less than IAT. Moreover, the test time for each plate (94 samples) is about 18 times less than that for IAT.
CONCLUSION: Jk(a-b-) phenotype screening by the direct urea lysis test on samples in a micro-titre plate is simple, cost-effective and practical for mass screening of blood donors.

Entities:  

Keywords:  Jk(a−b−) phenotype; Thai blood donors; urea lysis test

Mesh:

Substances:

Year:  2010        PMID: 20104274      PMCID: PMC2809507          DOI: 10.2450/2009.0104-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  13 in total

1.  Common problems in routine pre-transfusion testing.

Authors:  D Chandanayingyong
Journal:  Southeast Asian J Trop Med Public Health       Date:  1979-06       Impact factor: 0.267

2.  Severe hemolytic disease of the newborn caused by anti-Jka.

Authors:  G A MATSON; J SWANSON; J D TOBIN
Journal:  Vox Sang       Date:  1959-04       Impact factor: 2.144

Review 3.  Female alloimmunization with antibodies known to cause hemolytic disease.

Authors:  O Geifman-Holtzman; M Wojtowycz; E Kosmas; R Artal
Journal:  Obstet Gynecol       Date:  1997-02       Impact factor: 7.661

4.  Jk:-3 red cells have a defect in urea transport: a new urea-dependent lysis test.

Authors:  D C McDougall; M McGregor
Journal:  Transfusion       Date:  1988 Mar-Apr       Impact factor: 3.157

5.  Transfusion reaction. An immunologic hazard of blood transfusion.

Authors:  A A Pineda; H F Taswell; S M Brzica
Journal:  Transfusion       Date:  1978 Jan-Feb       Impact factor: 3.157

6.  Blood groups of the Thais.

Authors:  D Chandanayingyong; T T Sasaki; T J Greenwalt
Journal:  Transfusion       Date:  1967 Jul-Aug       Impact factor: 3.157

7.  Delayed hemolytic transfusion reaction with acute renal failure.

Authors:  P V Holland; R O Wallerstein
Journal:  JAMA       Date:  1968-06-10       Impact factor: 56.272

8.  Thalassemia in Thailand.

Authors:  P Wasi; S Pootrakul; P Pootrakul; P Pravatmuang; P Winichagoon; S Fucharoen
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

9.  Unexpected red cell antibodies in donors and patients at Siriraj Hospital.

Authors:  S Bejrachandra; D Chandanayingyong
Journal:  Southeast Asian J Trop Med Public Health       Date:  1979-06       Impact factor: 0.267

10.  Methods for the detection of Jk heterozygotes: interpretations and applications.

Authors:  J Edwards-Moulds; M R Kasschau
Journal:  Transfusion       Date:  1988 Nov-Dec       Impact factor: 3.157

View more
  9 in total

Review 1.  Rare gems: null phenotypes of blood groups.

Authors:  Willy A Flegel
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

2.  Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand.

Authors:  Pairaya Rujirojindakul; Willy A Flegel
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

3.  Improved allele-specific PCR technique for Kidd blood group genotyping.

Authors:  Kamphon Intharanut; Rudi Grams; Sasitorn Bejrachandra; Pramote Sriwanitchrak; Oytip Nathalang
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

Review 4.  The emerging physiological roles of the SLC14A family of urea transporters.

Authors:  Gavin Stewart
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  A rare case of anti-jk3 antibody detected on pre-transfusion investigation.

Authors:  Rabeya Yousuf; Suria Abdul Aziz; Nurasyikin Yusof; Chooi-Fun Leong
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-20       Impact factor: 0.900

6.  Genomic characterisation of the Jk(a-b-) phenotype in Thai blood donors.

Authors:  Pramote Sriwanitchrak; Kanchana Sriwanitchrak; Jintana Tubrod; Pawinee Kupatawintu; Chollanot Kaset; Oytip Nathalang
Journal:  Blood Transfus       Date:  2011-11-30       Impact factor: 3.443

7.  Red Cell Genotyping by Multiplex PCR Identifies Antigen-Matched Blood Units for Transfusion-Dependent Thai Patients.

Authors:  Kamphon Intharanut; Sasitorn Bejrachandra; Siriporn Nathalang; Nipapan Leetrakool; Oytip Nathalang
Journal:  Transfus Med Hemother       Date:  2017-05-12       Impact factor: 3.747

8.  Determining of JK*A and JK*B Allele Frequency Distribution among Muslim Blood Donors from Southern Thailand.

Authors:  Ubonwan Puobon; Kamphon Intharanut; Supattra Mitundee; Oytip Nathalang
Journal:  Malays J Med Sci       Date:  2019-02-28

9.  Impact of using genotyping to predict SERF negative phenotype in Thai blood donor populations.

Authors:  Oytip Nathalang; Kamphon Intharanut; Nipapan Leetrakool; Supattra Mitundee; Pawinee Kupatawintu
Journal:  Blood Res       Date:  2020-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.